Rinvoq
NDC 0074-1043 · AbbVie Inc.
Generic nameUpadacitinib
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)UPADACITINIB
Strength45 mg/1
Pharmacologic classJanus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
Marketing categoryNDA
Packages
0074-1043-14 — 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-14)
0074-1043-28 — 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-28)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0074-2306 — Upadacitinib, 0074-2310 — Upadacitinib, 0074-2320 — Upadacitinib